Transdermal & Intradermal Drug Delivery Systems 2017
September 28, 2017
Transdermal & Intradermal Drug Delivery Systems 2017 | Sept. 28-29 | Philadelphia
Want to Learn How to Bypass Costly Clinical Trials for Your Topical Products? Ask Us How In Philly!
A recent guidance from the FDA will allow acyclovir cream products to bypass human clinical trials, replacing them with a method using in vitro release testing (IVRT) and in vitro permeation testing (IVPT). Let Diteba, a Nutrasource company, show you how you may be able to save substantial time and money in your development program.
Theo Kapanadze, D.Sc., Ph.D., co-founder and chief scientific officer of Diteba, will also be presenting on “The Advances in Bioequivalence Assessment of Generic Topical Drugs,” at 8:00 a.m. on Friday, Sept. 29.
Schedule a meeting with us
Back to News